| 000 | 01792 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513030721.0 | ||
| 264 | 0 | _c19940325 | |
| 008 | 199403s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(93)90389-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSawaki, S | |
| 245 | 0 | 0 |
_aSelective inhibition by E4080, a novel bradycardic agent, of positive chronotropic responses to norepinephrine in isolated dog hearts. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cDec 1993 |
||
| 300 |
_a253-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a1-Methyl-3-isobutylxanthine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aBiological Clocks _xdrug effects |
| 650 | 0 | 4 |
_aCatechols _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclic AMP _xphysiology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xantagonists & inhibitors |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNorepinephrine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 |
_aSinoatrial Node _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xantagonists & inhibitors |
| 700 | 1 | _aFurukawa, Y | |
| 700 | 1 | _aInoue, Y | |
| 700 | 1 | _aOguchi, T | |
| 700 | 1 | _aChiba, S | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 250 _gno. 2 _gp. 253-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(93)90389-y _zAvailable from publisher's website |
| 999 |
_c7508751 _d7508751 |
||